R-MVST Cells for Treatment of Viral Infections

Abroad (travel likely)RecruitingPHASE1

Conditions

Epstein-Barr Virus Infections · Cytomegalovirus Infections · Adenovirus · BK Virus Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Columbia University Irving Medical Center, New York, New York, United States
Contact: Study coordinator (Pawel Muranski, MD) · pjm2170@cumc.columbia.edu · 212-305-9326
Contact: Principal Investigator (Pawel Muranski, MD)

Study leads

Pawel Muranski, MD
Principal Investigator
Assistant Professor of Medicine and Pathology and Cell Biology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Dengue · Chikungunya · Zika Virus Infection

Abroad (travel likely)Recruiting

Phnom Penh, Cambodia

Evaluation of CMV/EBV-CMI in Haploid HSCT

Hematopoietic Stem Cell Transplantation · Cytomegalovirus Infections · Epstein-Barr Virus Infections

Abroad (travel likely)Recruiting

Suzhou, China

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Epstein-Barr Virus Infection · Post-Transplant Lymphoproliferative Disorder

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Advanced Solid Tumors · Genital Neoplasm, Female · Urogenital Neoplasms

Abroad (travel likely)RecruitingPHASE1, PHASE2

Loma Linda, United States · Sacramento, United States